Medivir Ab Unsp/Adr

(MVRBY)

By |

Profile

Medivir AB is pharmaceutical research and development company. It develops pharmaceuticals for the treatment of cancer and specializes in protease inhibitor research and nucleotide science. The firm conducts research in all phases of pharmaceutical development from idea to clinical phase III studies. Its project pipeline includes Remetinostat, MIV-711, Birinapant, MIV-818, MIV-323 proprietary projects and also Olysio, JNJ-4178, Xerclear and MIV-802 partnership projects. The firm's products include Xerclear and Simprevir.

Contact Information

Website: www.medivir.se
Email: rein.piir@medivir.se
Main Phone: +46 854683100
Address: PO Box 1086
City / Town: Huddinge
Country: SWE
Postal Code: 141 22

Issuer Information

Exchange: GREY
Employees: 79
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 24,276,405.00 EPS (TTM) -1.95 PE Ratio N/A Exchange Greys